Diagnos Inc (ADK-X) Analyst Research & Price Targets - The Globe and Mail

Add to Watchlist Create Alerts

Delayed Last Update

Volume

Current Target Price

High Target Price

Mean Target Price

Low Target Price

Median Target Price

Earnings Estimates

	Current Qtr03/2024	Next Qtr06/2024	Fiscal Yr03/2024	Fiscal Yr03/2025
Average Estimate	-0.01	-0.01	-0.05	-0.02
Number of Estimates	1	1	1	1
High Estimate	-0.01	-0.01	-0.05	-0.02
Low Estimate	-0.01	-0.01	-0.05	-0.02
Prior Year	-0.01	-0.01	-0.04	-0.05
Growth Rate Est. (year over year)	unch	unch	-25.00%	+60.00%

Earnings History - Surprises*

	Qtr Ending12/2023	Qtr Ending09/2023	Qtr Ending06/2023	Qtr Ending03/2023
Reported	$-0.01	$-0.01	$-0.01	$-0.01
Estimate	$-0.01	$-0.01	$0.00	N/A
Difference	unch	unch	-0.01	N/A
Surprise	unch	unch	N/A	N/A

* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

4.00

3 Mths Ago1

4.00

2 Mths Ago1

4.00

1 Mth Ago1

4.00

Current1

Ratings Values:

Strong Buy5

Moderate Buy4

Hold3

Moderate Sell2

Strong Sell1

Ratings Breakdown

	3 Mths Ago	2 Mths Ago	1 Mth Ago	Current
# of Analysts:	1	1	1	1
	1	1	1	1
Holds	0	0	0	0

Key:

Strong Buy

Moderate Buy

Hold

Moderate Sell

Strong Sell

More from The Globe

The close: TSX higher as commodity prices climb

What every Canadian investor needs to know today

Speculative stock mania has returned. It’s not going to end well

George Athanassakos

Hoka-owner Deckers’ shares breach $1,000 mark for the first time

Short sales on the TSX: What bearish investors are betting against

Larry MacDonald

Reminder: The Globe Investing Club wants your stock picks

The close: Stocks rebound amid encouraging U.S. economic data

What every Canadian investor needs to know today